These selective checkpoint responses, cell cycle arrest, and/or cytotoxicity induced by RRP15-dependent ribosome stress in cells with different p53 function indicated that RRP15 might be a prospective target for cancer therapy. The gene discussed is RRP15; the disease is cancer.